JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staehelin, M.
Right arrow Articles by Wigger, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Staehelin, M.
Right arrow Articles by Wigger, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 258, Issue 6, 3496-3502, Mar, 1983

CGP-12177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells

M Staehelin, P Simons, K Jaeggi and N Wigger

A new, hydrophilic beta-adrenergic receptor radioligand, (+/-)-[3H]CGP- 12177 (4-(3-tertiarybutylamino-2-hydroxypropoxy)-benzimidazole-2-on hydrochloride), was synthesized and radiolabeled to 40 Ci/mmol. The nonspecific binding of this compound to turkey erythrocyte ghosts and C6 glioma cell membranes was less than 5% of the total binding at five times the appropriate KD. Binding assays of intact C6 glioma cells also showed low nonspecific binding, less than 20% of the total binding at five times the appropriate KD. The affinities of the antagonists (-)- and (+)-propranolol as well as of the agonist (-)-isoproterenol were examined by their potency to displace various radioligands from intact C6 glioma cell and membrane preparations. With membrane preparations, both [3H] CGP-12177 and [3H]dihydroalprenolol (DHA) were displaced stereospecifically by the antagonists (-)- and (+)-propranolol and the agonist (-)-isoproterenol. With whole cells, [3H]CGP-12177 and [3H]DHA behaved differently. [3H]DHA and [3H]carazolol could be stereospecifically displaced by antagonists but only partially displaced by agonists, while [3H]CGP-12177 could be completely displaced by both antagonists and agonists as in membranes. In contrast to [3H]CGP-12177, the lipophilic ligand [3H]DHA is actually taken up by cells. The inability of agonists to displace lipophilic radioligands from receptors on intact cells may not be due to a low affinity of agonists for receptors on cells, but to an agonist-induced change in the receptors which renders them inaccessible to hydrophilic agonists and antagonists. This change is likely to be their internalization into the cell.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JNMHome page
T. Tsukamoto, K. Morita, M. Naya, M. Inubushi, C. Katoh, K. Nishijima, Y. Kuge, H. Okamoto, H. Tsutsui, and N. Tamaki
Decreased Myocardial {beta}-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy
J. Nucl. Med., November 1, 2007; 48(11): 1777 - 1782.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. G. Baker
Site of Action of {beta}-Ligands at the Human {beta}1-Adrenoceptor
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1163 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Cheng, F. Qiao, T. N. Gallien, D. Kuppuswamy, and G. Cooper IV
Inhibition of {beta}-adrenergic receptor trafficking in adult cardiocytes by MAP4 decoration of microtubules
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1193 - H1202.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Breit, M. Lagace, and M. Bouvier
Hetero-oligomerization between {beta}2- and {beta}3-Adrenergic Receptors Generates a {beta}-Adrenergic Signaling Unit with Distinct Functional Properties
J. Biol. Chem., July 2, 2004; 279(27): 28756 - 28765.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Gardner, N. M. D. Santos, S. G. Matta, M. A. Whitt, and S. W. Bahouth
Role of the Cyclic AMP-dependent Protein Kinase in Homologous Resensitization of the {beta}1-Adrenergic Receptor
J. Biol. Chem., May 14, 2004; 279(20): 21135 - 21143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. C. Simons, S. M. Biggs, A. Waller, T. Foutz, D. F. Cimino, Q. Guo, R. R. Neubig, W.-J. Tang, E. R. Prossnitz, and L. A. Sklar
Real-time Analysis of Ternary Complex on Particles: DIRECT EVIDENCE FOR PARTIAL AGONISM AT THE AGONIST-RECEPTOR-G PROTEIN COMPLEX ASSEMBLY STEP OF SIGNAL TRANSDUCTION
J. Biol. Chem., April 2, 2004; 279(14): 13514 - 13521.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Leblais, F. Pourageaud, M. D. Ivorra, C. Guibert, R. Marthan, and B. Muller
Role of {alpha}-Adrenergic Receptors in the Effect of the {beta}-Adrenergic Receptor Ligands, CGP 12177, Bupranolol, and SR 59230A, on the Contraction of Rat Intrapulmonary Artery
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 137 - 145.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Jakubik, S. Tucek, and E. E. El-Fakahany
Role of Receptor Protein and Membrane Lipids in Xanomeline Wash-Resistant Binding to Muscarinic M1 Receptors
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 105 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Shi, G. Liapakis, R. Xu, F. Guarnieri, J. A. Ballesteros, and J. A. Javitch
beta 2 Adrenergic Receptor Activation. MODULATION OF THE PROLINE KINK IN TRANSMEMBRANE 6 BY A ROTAMER TOGGLE SWITCH
J. Biol. Chem., October 18, 2002; 277(43): 40989 - 40996.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Bundkirchen, K. Brixius, B. Bolck, and R. H. G. Schwinger
Bucindolol Exerts Agonistic Activity on the Propranolol-Insensitive State of beta 1-Adrenoceptors in Human Myocardium
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 794 - 801.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Delforge, D. Mesangeau, F. Dolle, P. Merlet, C. Loc'h, M. Bottlaender, R. Trebossen, and A. Syrota
In Vivo Quantification and Parametric Images of the Cardiac {beta}-Adrenergic Receptor Density
J. Nucl. Med., February 1, 2002; 43(2): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Granneman
The putative {beta}4-adrenergic receptor is a novel state of the {beta}1-adrenergic receptor
Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E199 - E202.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Shan, R. J. Bick, B. J. Poindexter, S. F. Nagueh, S. Shimoni, M. S. Verani, F. Keng, M. J. Reardon, G. V. Letsou, J. F. Howell, et al.
Altered Adrenergic Receptor Density in Myocardial Hibernation in Humans : A Possible Mechanism of Depressed Myocardial Function
Circulation, November 21, 2000; 102(21): 2599 - 2606.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Shan, R. J. Bick, B. J. Poindexter, S. Shimoni, G. V. Letsou, M. J. Reardon, J. F. Howell, W. A. Zoghbi, and S. F. Nagueh
Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans
J. Am. Coll. Cardiol., September 1, 2000; 36(3): 891 - 896.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Konkar, Z. Zhu, and J. G. Granneman
Aryloxypropanolamine and Catecholamine Ligand Interactions with the beta 1-Adrenergic Receptor: Evidence for Interaction with Distinct Conformations of beta 1-Adrenergic Receptors
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 923 - 932.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. A. Konkar, Y. Zhai, and J. G. Granneman
beta 1-Adrenergic Receptors Mediate beta 3-Adrenergic-Independent Effects of CGP 12177 in Brown Adipose Tissue
Mol. Pharmacol., February 1, 2000; 57(2): 252 - 258.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. Bronnikov, T. Bengtsson, L. Kramarova, V. Golozoubova, B. Cannon, and J. Nedergaard
{beta}1 to {beta}3 Switch in Control of Cyclic Adenosine Monophosphate during Brown Adipocyte Development Explains Distinct {beta}-Adrenoceptor Subtype Mediation of Proliferation and Differentiation
Endocrinology, September 1, 1999; 140(9): 4185 - 4197.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Ohta, X.-P. Pang, L. Berg, and J. M. Hershman
Growth Inhibition of New Human Thyroid Carcinoma Cell Lines by Activation of Adenylate Cyclase through the {beta}-Adrenergic Receptor
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2633 - 2638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Javitch, D. Fu, G. Liapakis, and J. Chen
Constitutive Activation of the beta 2 Adrenergic Receptor Alters the Orientation of Its Sixth Membrane-spanning Segment
J. Biol. Chem., July 25, 1997; 272(30): 18546 - 18549.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Moore, N Sadovnikoff, S Hoffenberg, S Liu, P Woodford, K Angelides, J. Trial, N. Carsrud, B. Dickey, and B. Knoll
Ligand-stimulated beta 2-adrenergic receptor internalization via the constitutive endocytic pathway into rab5-containing endosomes
J. Cell Sci., January 9, 1995; 108(9): 2983 - 2991.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1983 by the American Society for Biochemistry and Molecular Biology.